Esther Barak-Landes Launches $40 Million Fund for Mental Health and Longevity Tech
Translated & summarized from Ice by baba
Esther Barak-Landes, daughter of former Supreme Court President Aharon Barak, is launching a new $40 million venture capital fund called Alma. The fund will invest in mental health and longevity technologies, partnering with Sheba Medical Center for clinical research. This initiative follows a significant growth in Israel's mental health tech sector, with a philanthropic arm aiming to improve access to treatments for over a million people by 2035.
The story in 5 lines · by baba
- Esther Barak-Landes is launching a new $40 million venture capital fund named Alma.
- The fund will focus on investments in mental health and brain technologies, as well as longevity.
- Alma is partnering with Sheba Medical Center to test and develop medical solutions.
- Israeli mental health tech companies saw a 150% funding increase between 2024 and 2025.
- The initiative includes a philanthropic arm aiming to improve access to mental health treatments.
Esther Barak-Landes, daughter of former Supreme Court President Aharon Barak, is launching a new venture capital fund named Alma, which is in the advanced stages of raising approximately $40 million. Barak-Landes, who has over 25 years of experience in tech investments and has been involved in numerous successful exits, is shifting her focus to the burgeoning fields of mental health and brain technology, as well as longevity.
The Alma fund will invest in solutions for treating conditions such as depression, addiction, dementia, and trauma. The longevity aspect aims to extend the period of healthy human life by slowing aging processes and reducing age-related diseases, rather than promising immortality. This approach focuses on early identification and intervention for potential health issues.
Alma is establishing a strategic partnership with the Sheba Medical Center, which already operates a dedicated longevity center. This collaboration will enable young technology companies to test medical solutions in a clinical setting, conduct research, and develop products for the international market.
The focus on mental health technology is driven by a significant increase in demand for treatment and rehabilitation solutions. Israeli companies in this sector raised approximately $352 million in 2025, a 150% jump from $138 million in 2024, with around 178 companies currently operating in the field.
In addition to its commercial investment activities, the initiative includes a separate philanthropic arm, the ALMA Foundation. This foundation aims to promote medical research and clinical trials that may not receive private funding. The venture has set an ambitious goal to provide over one million people with improved access to mental and brain health treatments by 2035.
Mentioned
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Other 2
